Application 012703

Type
NDA
Sponsor
ASTRAZENECA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
006ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
007ELAVILAMITRIPTYLINE HYDROCHLORIDETABLET;ORAL150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
44001ORIG2007-05-09
12031SUPPL2003-08-06
339SUPPL2001-03-27